Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02875704 · ClinicalTrials.gov registry record
Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy
A clinical trial, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- 77
- Enrollment target
NCT02875704: Clinical Trial study, sponsored by Johns Hopkins University.
NCT02875704 is a clinical trial that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02875704 was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- 77 participants
- Enrollment target
Study Summary
In this study, markers of oxidative stress will be measured in the aqueous humour of stargardt disease, age related macular degeneration and diabetic retinopathy patients compared to controls.
Interventions
- OTHER Anterior Chamber (AC) Tap
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2017-01-03 |
| Est. Completion | 2022-09-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02875704
The ClinicalTrials.gov registry entry for NCT02875704 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Anterior Chamber (AC) Tap is the first listed.
NCT02875704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02875704 about?
NCT02875704 is a clinical study titled "Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy". In this study, markers of oxidative stress will be measured in the aqueous humour of stargardt disease, age related macular degeneration and diabetic retinopathy patients compared to controls.
What is the current status of trial NCT02875704?
This trial is currently terminated. The enrollment target is 77 participants. The study started on 2017-01-03. Estimated completion is 2022-09-22.
What interventions are being tested in trial NCT02875704?
The interventions under investigation include: Anterior Chamber (AC) Tap (OTHER).
Who is sponsoring clinical trial NCT02875704?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.